Literature DB >> 32859254

Predictive value of neutrophil to lymphocyte and platelet to lymphocyte ratio in COVID-19.

Shiping Zhu1, Lei Dong2, Wanru Cai3.   

Abstract

Entities:  

Keywords:  COVID-19; Neutrophil to leucocyte ratio; Platelet to lymphocyte ratio

Mesh:

Substances:

Year:  2020        PMID: 32859254      PMCID: PMC7453860          DOI: 10.1186/s13054-020-03258-x

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
To the Editor, In a recent study, Dr. Ma [1] investigated the neutrophil to lymphocyte ratio (NLR) in predicting moderate-severe acute respiratory distress syndrome (ARDS) in patients with COVID-19 infection. They reported that NLR was significantly higher ARDS group and was a good predictor for moderate-severe ARDS, with area under curve (AUC) 0.749. This study is well designed. However, several limitations should be mentioned. First, uncontrolled inflammatory response plays a vital role in COVID-19 disease, and both NLR and platelet to lymphocyte ratio (PLR) have been recognized as inflammatory factors in various lung diseases [2, 3], such as lung cancer and obstructive lung disease. However, one common limitation is that in most previous studies, NLR or PLR was included in the generalized linear models as a continuous variable, with the assumption that there was a linear association between NLR/PLR and the dependent outcomes. Even in some prediction model [4], researchers only focused on the impact of higher NLR/PLR value while the effect of low NLR/PLR was ignored. However, in most cases, extremely low NLR or PLR represented low neutrophil and platelet, which, according to clinical experience, was also associated with poor outcomes. Thus, the association between NLR/PLR and outcomes should be non-linear, and simply including these parameters into a linear model may lead to a biased conclusion. For instance, we estimated an unadjusted association between NLR/PLR and mortality in critically ill patients with lung infection, using data from the MIMIC database (Fig. 1). Although the cohort is different from the current study, the non-linear association, to a certain degree, supports our hypothesis. If this is the case, the predictive value of NLR/PLR in AUC may also be compromised as both high and low NLR/PLR was associated with increased mortality. The following method may improve this limitation: (1) applying non-linear spline regression using the cut-off value of NLR/PLR in logistic model, (2) generating predictive values of the logistic model, and (3) calculating the AUC of the predictive value in predicting mortality. Finally, we thank Dr. Ma et al. for their valuable research.
Fig. 1

Non-linear association between NLR/PLR and in-hospital death in patients with lung infection. Abbreviations: NLR neutrophil to lymphocyte, PLR platelet to lymphocyte

Non-linear association between NLR/PLR and in-hospital death in patients with lung infection. Abbreviations: NLR neutrophil to lymphocyte, PLR platelet to lymphocyte
  4 in total

1.  Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer.

Authors:  Yu-Qian Wang; Qiong-Jie Zhi; Xin-Yue Wang; Dong-Sheng Yue; Kai Li; Ri-Cheng Jiang
Journal:  Oncol Lett       Date:  2017-07-24       Impact factor: 2.967

2.  Relationship between neutrophil-lymphocyte ratio and short-term prognosis in the chronic obstructive pulmonary patients with acute exacerbation.

Authors:  Jia Liu; Jie Liu; Yong Zou
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

3.  Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.

Authors:  Aijia Ma; Jiangli Cheng; Jing Yang; Meiling Dong; Xuelian Liao; Yan Kang
Journal:  Crit Care       Date:  2020-06-05       Impact factor: 9.097

4.  Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study.

Authors:  Shuai Zhang; Mengfei Guo; Limin Duan; Feng Wu; Guorong Hu; Zhihui Wang; Qi Huang; Tingting Liao; Juanjuan Xu; Yanling Ma; Zhilei Lv; Wenjing Xiao; Zilin Zhao; Xueyun Tan; Daquan Meng; Shujing Zhang; E Zhou; Zhengrong Yin; Wei Geng; Xuan Wang; Jianchu Zhang; Jianguo Chen; Yu Zhang; Yang Jin
Journal:  Crit Care       Date:  2020-07-16       Impact factor: 9.097

  4 in total
  5 in total

1.  Effects of Purinergic Receptor Deletion or Pharmacologic Modulation on Pulmonary Inflammation in Mice.

Authors:  Gregory S Whitehead; Tadeusz P Karcz; Dilip K Tosh; Young-Hwan Jung; Zhiwei Wen; Ryan G Campbell; Varun Gopinatth; Zhan-Guo Gao; Kenneth A Jacobson; Donald N Cook
Journal:  ACS Pharmacol Transl Sci       Date:  2022-10-05

2.  Distribution and reference interval establishment of neutral-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in Chinese healthy adults.

Authors:  Junjun Wang; Fan Zhang; Feng Jiang; Lijuan Hu; Jian Chen; Yumin Wang
Journal:  J Clin Lab Anal       Date:  2021-08-13       Impact factor: 3.124

Review 3.  P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo-inflammation.

Authors:  Lyvia Lintzmaier Petiz; Talita Glaser; Julio Scharfstein; Mariusz Z Ratajczak; Henning Ulrich
Journal:  Stem Cell Rev Rep       Date:  2021-02-11       Impact factor: 5.739

4.  A Retrospective Cohort Study of Clinical Factors Associated with Transitions of Care among COVID-19 Patients.

Authors:  Dennis Swearingen; Gregory Boverman; Kristen Tgavalekos; David P Noren; Shreyas Ravindranath; Erina Ghosh; Minnan Xu; Lisa Wondrely; Pam Thompson; J David Cowden; Corneliu Antonescu
Journal:  J Clin Med       Date:  2021-10-08       Impact factor: 4.241

5.  Correlation Between Platelet-Lymphocyte Ratio and Neutrophil-Lymphocyte Ratio in Patients with Uterine Leiomyoma: A Cross-Sectional Study.

Authors:  Yanan Duan; Yiqing Peng; Xiuling Shi; Ying Zhao; Kunyan Liu; Runsheng Zhou; Cunxu Peng
Journal:  J Oncol       Date:  2022-08-11       Impact factor: 4.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.